from Yahoo Finance https://ift.tt/2YXxVPV
-
LabCorp expands availability of at-home sample collection kit for COVID-19 testing
from Yahoo Finance https://ift.tt/2T1fHcN
-
U.S. FDA declines to review Bristol Myers, bluebird therapy for multiple myeloma
from Yahoo Finance https://ift.tt/2WUgWeC
The Latest
-
ASX 200 energy share with ‘material long-term upside’ ahead: fundie
-
Leading broker says this top ASX 200 share is a buy with 25%+ upside
-
EBOS Group trims FY26 earnings guidance as fuel costs bite
-
Want to build a second income? I’d buy these ASX shares today